← Back to Search

Hospitalized Medical Patients for Deep Vein Thrombosis

N/A
Waitlist Available
Research Sponsored by Intermountain Health Care, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 to 180 days
Awards & highlights

Summary

A systematic review and meta analysis will be performed of risk assessment models for Venous thromboembolism ("VTE" including pulmonary embolism "PE" and deep venous thrombosis "DVT")in hospitalized medical patients. The goal of this study is to evaluate whether the incidence of VTE is lower in patients that are evaluated with a risk assessment model and treated with thromboprophylaxis for their assigned level of risk.

Eligible Conditions
  • Deep Vein Thrombosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 to 180 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 to 180 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
VTE

Trial Design

1Treatment groups
Experimental Treatment
Group I: Hospitalized Medical PatientsExperimental Treatment1 Intervention
All hospitalized medical adult patients

Find a Location

Who is running the clinical trial?

Intermountain Health Care, Inc.Lead Sponsor
139 Previous Clinical Trials
1,963,960 Total Patients Enrolled
5 Trials studying Deep Vein Thrombosis
2,719 Patients Enrolled for Deep Vein Thrombosis
Scott C Woller, MDStudy DirectorIntermountain Health Care, Inc.
1 Previous Clinical Trials
48 Total Patients Enrolled
~0 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top